These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hemorrhagic shock prevents lung microvascular permeability and hypoxemia associated with complement activation in the awake sheep. Krausz MM; Shilo L; Moriel E; Perel A; Eldor A; Durst AL Circ Shock; 1987; 23(1):7-26. PubMed ID: 3690815 [TBL] [Abstract][Full Text] [Related]
3. The effect of a single infusion of zymosan-activated plasma on the pulmonary microcirculation of sheep. Structure-function relationships. Meyrick BO; Brigham KL Am J Pathol; 1984 Jan; 114(1):32-45. PubMed ID: 6691415 [TBL] [Abstract][Full Text] [Related]
4. Thromboxane as a mediator of pulmonary dysfunction during intravascular complement activation in sheep. Gee MH; Perkowski SZ; Tahamont MV; Flynn JT; Wasserman MA Am Rev Respir Dis; 1986 Feb; 133(2):269-73. PubMed ID: 3753832 [TBL] [Abstract][Full Text] [Related]
5. Failure of therapy with 2,3-dihydroxybenzoic acid to modify the course of sepsis-induced lung injury. Sharpe MD; Mustard RA; Finley RR; Rutledge FS; Sibbald WJ J Appl Physiol (1985); 1990 Nov; 69(5):1893-902. PubMed ID: 2272983 [TBL] [Abstract][Full Text] [Related]
6. Effects of hypoxia and complement activation on lung hemodynamics and fluid exchanges in unanesthetized goats. Xie ZL; Sun BY; Li DQ Respiration; 1989; 56(3-4):147-53. PubMed ID: 2635343 [TBL] [Abstract][Full Text] [Related]
9. Contribution of circulating formed elements to prostanoid production in complement-mediated lung injury in sheep. Egan TM; Saunders NR; Dubois P; Choiniere L; McDonald JW; Cooper JD Surgery; 1985 Aug; 98(2):350-8. PubMed ID: 4023926 [TBL] [Abstract][Full Text] [Related]
10. The effect of an infusion of zymosan-activated plasma on hemodynamic and pulmonary function in sheep. Sharkey P; Judges D; Driedger AA; Cheung H; Finley RJ; Sibbald WJ Circ Shock; 1984; 12(2):79-93. PubMed ID: 6705153 [TBL] [Abstract][Full Text] [Related]
11. Species variability in the cardiovascular and hematologic effects of zymosan-activated plasma infusion. Casey LC; Fletcher JR; Chernow B; Ramwell PW J Surg Res; 1986 Mar; 40(3):202-9. PubMed ID: 3951216 [TBL] [Abstract][Full Text] [Related]
12. Effect of complement activation with cobra venom factor on pulmonary vascular permeability. Johnson A; Cooper JA; Malik AB J Appl Physiol (1985); 1986 Dec; 61(6):2202-9. PubMed ID: 3027023 [TBL] [Abstract][Full Text] [Related]
13. Effects of L-652,731, a platelet-activating factor (PAF) receptor antagonist, on PAF- and complement-induced pulmonary hypertension in sheep. Smallbone BW; Taylor NE; McDonald JW J Pharmacol Exp Ther; 1987 Sep; 242(3):1035-40. PubMed ID: 2821222 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of complement activation induced by cobra venom factor on pulmonary transvascular fluid and protein exchange. Johnson A; Blumenstock FA; Hussain M; Malik AB Am J Pathol; 1984 Mar; 114(3):410-7. PubMed ID: 6696049 [TBL] [Abstract][Full Text] [Related]
15. Effects of repetitive bolus injections of zymosan-activated plasma on lung mechanics and airway responsiveness in awake sheep. Snapper JR; Butterfield MJ; Rayburn DB; Lefferts PL Am Rev Respir Dis; 1991 Mar; 143(3):578-84. PubMed ID: 2001069 [TBL] [Abstract][Full Text] [Related]
16. Role of intrapulmonary release of eicosanoids and superoxide anion as mediators of pulmonary dysfunction and endothelial injury in sheep with intermittent complement activation. Perkowski SZ; Havill AM; Flynn JT; Gee MH Circ Res; 1983 Nov; 53(5):574-83. PubMed ID: 6313251 [TBL] [Abstract][Full Text] [Related]
17. Perilla ketone: a model of increased pulmonary microvascular permeability pulmonary edema in sheep. Coggeshall JW; Lefferts PL; Butterfield MJ; Bernard GR; Carroll FE; Pou NA; Snapper JR Am Rev Respir Dis; 1987 Dec; 136(6):1453-8. PubMed ID: 3688648 [TBL] [Abstract][Full Text] [Related]